Chelsea Nahavandi

Chelsea Nahavandi has accumulated several years of experience in the biotechnology industry. Chelsea currently works at Encoded Therapeutics Inc. as a Scientist I, a role they have held since March 2022. Prior to that, they were a Senior Process Development Associate at the same company from August 2020 to March 2022. Chelsea also worked as a Process Development Associate II at Encoded Therapeutics Inc. from November 2019 to August 2020. Before joining Encoded Therapeutics Inc., they were a Research Associate II at Five Prime Therapeutics, Inc., where they supported mammalian cell culture experiments for Upstream Process Development. Chelsea began their career as a Laboratory Technician at StemExpress, where they worked from October 2014 to October 2015. Chelsea also had a brief stint as a Laboratory Technician at StemExpress from October 2014 to December 2014. Chelsea has a strong background in process development and technical expertise in bioreactor systems and data analysis.

Chelsea Nahavandi attended UC Santa Barbara from 2010 to 2014 where they obtained a Bachelor of Science (BS) degree in Biological Sciences. In August 2019, they also obtained a certification in JMP Software: Anova & Regression from SAS.